Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Poli

Showing results (171-180 of 212) with videos related to

Pageof 22
Sort By:
European Journal of Neurology|September 3, 2021
Simulation-based training improves process times in acute stroke care (STREAM)Ferdinand O Bohmann, Katharina Gruber, Natalia Kurka, et al.
The Lancet Regional Health. Europe|December 11, 2023
Prevention of infections and fever to improve outcome in older patients with acute stroke (PRECIOUS): a randomised, open, phase III, multifactorial, clinical trial with blinded outcome assessmentJeroen C de Jonge, Wouter M Sluis, Hendrik Reinink, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|June 6, 2023
Cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia in middle-income countriesAnita van de Munckhof, Afshin Borhani-Haghighi, Sanjith Aaron, et al.
Thrombosis and Haemostasis|February 5, 2024
Algorithm for Rapid Exclusion of Clinically Relevant Plasma Levels of Direct Oral Anticoagulants in Patients Using the DOAC Dipstick: An Expert Consensus PaperJob Harenberg, Robert C Gosselin, Adam Cuker, et al.
Thrombosis and Haemostasis|November 27, 2025
Erratum: Algorithm for Rapid Exclusion of Clinically Relevant Plasma Levels of Direct Oral Anticoagulants in Patients Using the DOAC Dipstick: An Expert Consensus PaperJob Harenberg, Robert C Gosselin, Adam Cuker, et al.
Frontiers in Neurology|October 8, 2024
Corrigendum: Direct oral anticoagulants for the treatment of cerebral venous thrombosis - a protocol of an international phase IV studyAnita van de Munckhof, Mayte Sánchez van Kammen, Katarzyna Krzywicka, et al.
NEJM Evidence|February 6, 2024
Apixaban versus Aspirin for Embolic Stroke of Undetermined SourceTobias Geisler, Timea Keller, Peter Martus, et al.
Stroke|August 20, 2025
Early Thrombolysis and Outcomes in Central Retinal Artery Occlusion: An Individual Participant Data Meta-AnalysisJim S Xie, Kirill Zaslavsky, Yuri Chaban, et al.
Frontiers in Neurology|October 2, 2023
Direct oral anticoagulants for the treatment of cerebral venous thrombosis - a protocol of an international phase IV studyAnita van de Munckhof, Mayte Sánchez van Kammen, Katarzyna Krzywicka, et al.
The New England Journal of Medicine|May 15, 2024
Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral HemorrhageStuart J Connolly, Mukul Sharma, Alexander T Cohen, et al.
Pageof 22

Showing results (171-180 of 212) with videos related to

Sort By:
Pageof 22
European Journal of Neurology|September 3, 2021
Simulation-based training improves process times in acute stroke care (STREAM)Ferdinand O Bohmann, Katharina Gruber, Natalia Kurka, et al.
The Lancet Regional Health. Europe|December 11, 2023
Prevention of infections and fever to improve outcome in older patients with acute stroke (PRECIOUS): a randomised, open, phase III, multifactorial, clinical trial with blinded outcome assessmentJeroen C de Jonge, Wouter M Sluis, Hendrik Reinink, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|June 6, 2023
Cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia in middle-income countriesAnita van de Munckhof, Afshin Borhani-Haghighi, Sanjith Aaron, et al.
Thrombosis and Haemostasis|February 5, 2024
Algorithm for Rapid Exclusion of Clinically Relevant Plasma Levels of Direct Oral Anticoagulants in Patients Using the DOAC Dipstick: An Expert Consensus PaperJob Harenberg, Robert C Gosselin, Adam Cuker, et al.
Thrombosis and Haemostasis|November 27, 2025
Erratum: Algorithm for Rapid Exclusion of Clinically Relevant Plasma Levels of Direct Oral Anticoagulants in Patients Using the DOAC Dipstick: An Expert Consensus PaperJob Harenberg, Robert C Gosselin, Adam Cuker, et al.
Frontiers in Neurology|October 8, 2024
Corrigendum: Direct oral anticoagulants for the treatment of cerebral venous thrombosis - a protocol of an international phase IV studyAnita van de Munckhof, Mayte Sánchez van Kammen, Katarzyna Krzywicka, et al.
NEJM Evidence|February 6, 2024
Apixaban versus Aspirin for Embolic Stroke of Undetermined SourceTobias Geisler, Timea Keller, Peter Martus, et al.
Stroke|August 20, 2025
Early Thrombolysis and Outcomes in Central Retinal Artery Occlusion: An Individual Participant Data Meta-AnalysisJim S Xie, Kirill Zaslavsky, Yuri Chaban, et al.
Frontiers in Neurology|October 2, 2023
Direct oral anticoagulants for the treatment of cerebral venous thrombosis - a protocol of an international phase IV studyAnita van de Munckhof, Mayte Sánchez van Kammen, Katarzyna Krzywicka, et al.
The New England Journal of Medicine|May 15, 2024
Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral HemorrhageStuart J Connolly, Mukul Sharma, Alexander T Cohen, et al.
Pageof 22